PMC9848047_01
CT with oral contrast revealing a soft tissue ampullary lesion on axial and coronal images.
rjac621f1.jpg
PMC9848047_01_rjac621f1.jpg
f1
AKI. Additionally, the periportal, intraabdominal and epicardial lymph nodes were mildly prominent (Fig. 1).
(A) and (B) malignant appearing soft tissue infiltrative mass within the ampulla of Vater seen on ERCP; (C) cholangiopancreatography showing stenosed distal third of the common bile duct along with a patent pancreatic duct.
rjac621f2.jpg
PMC9848047_01_rjac621f2.jpg
f2
A tapered tip cannula was inserted through the ampulla and contrast was injected, revealing a patent PD and a single 18-mm long stenosis of the distal third of the CBD with significant dilatation of the proximal CBD and intrahepatic ducts (Fig. 2).
(A) and (B) endoscopic images showing a single plastic stent inserted into the distal CBD, protruding into the second part of the duodenum; (C) position confirmed on cholangiopancreatography revealing resolution of distal CBD filling defect.
rjac621f3.jpg
PMC9848047_01_rjac621f3.jpg
f3
Cholangiopancreatography revealed the stent was in good position with good flow of contrast into the duodenum beyond the filling defect (Fig. 3).
(A) H&E x400 slide showing pigmented melanoma cells with surrounding normal tissue; (B) H&E x40 slide with normal ampulla tissue on far left and tumour in centre; (C) MelanA x200 stain with melanoma; and adjacent normal ampullary tissue on the left; cytoplasmic expression of MelanA/MART1 highlights how the melanocytes are obscured by a dense lymphocytic infiltrate than in the conventional H&E slide; (D) Sox10 stain x200 similarly showing discoloration by malignant melanoma cells with surrounding normal ampullary tissue.
rjac621f4.jpg
PMC9848047_01_rjac621f4.jpg
f4
Histopathology of the ampullary lesions collected at ERCP showed evidence of malignant large cell tumour with diffuse and focally nested proliferation of epithelioid-shaped cells positive for Melan-A and Sox10 on immunohistochemistry, which was consistent with malignant melanoma (Fig. 4).